US Broker Ratings

Waters Corporation (WAT) Stock Analysis: A 5% Upside Potential with Strong Buy Ratings in the Healthcare Sector

Waters Corporation (NYSE: WAT) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Milford, Massachusetts, the company provides advanced analytical workflow..

STERIS plc (STE) Stock Analysis: A Healthcare Powerhouse with 28% Potential Upside

Investors with an eye on the healthcare sector should take a closer look at STERIS plc (NYSE: STE), a leader in infection prevention products and services. With a current market..

Fresenius Medical Care AG (FMS) Stock Analysis: Evaluating a 15% Potential Upside Amidst Diverse Analyst Opinions

Fresenius Medical Care AG (NYSE: FMS), a leading player in the healthcare sector, specializes in providing comprehensive dialysis and related services for individuals with renal diseases. With operations spanning globally,..

Incyte Corporation (INCY) Stock Analysis: Navigating Biotech Growth with a 37.7% Revenue Surge

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, presents a compelling case for investors with its robust revenue growth and strategic positioning in the healthcare industry. Headquartered..

The Cooper Companies, Inc. (COO): Investor Outlook Reveals 19.76% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, offers compelling insights for investors keen on capitalizing on..

Mettler-Toledo International (MTD) Stock Analysis: Navigating a 4.32% Upside in the Diagnostics & Research Sector

Mettler-Toledo International Inc. (NYSE: MTD), a Swiss powerhouse in the Diagnostics & Research industry, presents a promising opportunity for investors with its currently evaluated market cap of $27.9 billion. Positioned..

Illumina, Inc. (ILMN) Stock Analysis: Navigating a Complex Landscape with High Growth Potential

Illumina, Inc. (NASDAQ: ILMN), a pioneering entity in the healthcare sector, specifically in diagnostics and research, continues to capture investor attention despite a challenging market environment. With a market capitalization..

Biogen Inc. (BIIB) Stock Analysis: Navigating Market Dynamics with Potential 10.53% Upside

Biogen Inc. (NASDAQ: BIIB), a seasoned player in the healthcare sector, continues to capture investor attention with its robust pipeline and strategic collaborations. With a market capitalization of $31.84 billion,..

United Therapeutics Corporation (UTHR) Stock Analysis: Strong Buy Ratings and a 34% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) is making waves in the healthcare sector with its innovative solutions targeting chronic and life-threatening diseases. Founded in 1996 and headquartered in Silver Spring, Maryland,..

GSK plc (GSK) Investor Outlook: Exploring an 18% Upside Potential in the Healthcare Sector

Investors with an eye on the healthcare industry might find GSK plc (NYSE: GSK) a compelling option given its robust position in the global drug manufacturing space. With a market..

Cencora, Inc. (COR) Stock Analysis: Unveiling a 19.6% Potential Upside in the Healthcare Distribution Sector

For investors keen on the healthcare distribution sector, Cencora, Inc. (NYSE: COR) presents a compelling opportunity. With a robust market capitalization of $58.92 billion and a significant potential upside of..

Baxter International Inc. (BAX) Stock Analysis: Assessing a 26% Potential Upside Amid Healthcare Sector Challenges

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, presents an intriguing opportunity for investors looking to capitalize on its diverse product portfolio and expansive market reach. Operating..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 10% Upside Potential with Strong Revenue Growth

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, stands out in the medical care facilities industry with its robust growth metrics and an intriguing stock..

Bristol-Myers Squibb (BMY) Stock Analysis: A Healthcare Giant with 5.79% Upside Potential

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to capture investor attention with its robust portfolio of biopharmaceutical products. With a market capitalization of $128.81 billion,..

Centene Corporation (CNC) Stock Analysis: Unveiling Growth Potential Amidst a Healthcare Sector Resurgence

Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry, captures investor interest with its strategic positioning in the managed care domain. With a market capitalization of $32.16..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 27.81% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable player in the healthcare sector, with a market capitalization of $338.3 billion, signifying its considerable influence and stability within the industry...

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Insights on a 21% Potential Upside for Investors

Intuitive Surgical, Inc. (NASDAQ: ISRG) is a prominent player in the healthcare sector, particularly known for its sophisticated medical instruments and supplies. Headquartered in Sunnyvale, California, Intuitive Surgical has carved..

BioNTech SE (BNTX) Stock Analysis: Navigating a 23% Potential Upside Amidst Challenging Financials

BioNTech SE (BNTX), a German biotechnology powerhouse, has garnered significant attention in the healthcare sector for its pioneering work in immunotherapies and mRNA vaccine development. Despite the recent financial turbulence,..

AbbVie Inc. (ABBV) Stock Analysis: Navigating Growth with a 5.55% Upside Potential

AbbVie Inc. (NYSE: ABBV), a stalwart in the healthcare sector, continues to capture investor attention with its robust pipeline and strategic market position. As a research-based biopharmaceutical company, AbbVie is..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds